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http://dx.doi.org/10.1016/j.asjsur.20Summary Background: Splenectomy is a common surgical procedure, but few reports focus
on nontraumatic splenectomies. The aim of this study was to determine the predictors of
morbidity and mortality of patients submitted to elective nontraumatic splenectomy.
Methods: A descriptive cross-sectional study of 152 consecutive, nonselected, nontraumatic
patients operated on by splenectomy between 1996 and 2010 was carried out. Clinical, labo-
ratory, and surgical data, histological findings, perioperative mortality, and postoperative
complications according to Clavien-Dindo classification, were recorded. Factors related to
morbidity and mortality were analyzed.
Results: Of the 152 patients (89 male and 63 female; mean age 49.8  17.8 years), 74 (48.7%)
were operated on for malignant hematologic disorders, 44 for benign hematologic process, and
34 for other nonhematologic disorders. The spleen was enlarged in 95 patients (62.5%) and 78
patients (51.3%) had hypersplenism. The overall complications rate was 40.1%: Grades I and II
in 27 cases (17.7%), and Grades III and IV in 23 patients (15.1%). Perioperative mortality was
7.2% (11 patients). In univariate analysis, significant negative predictors for morbidity were
age (p Z 0.004), anemia (p Z 0.03), leukocytosis (p Z 0.016), and blood transfusions
(p < 0.001). In the multivariate analysis, only the need for blood transfusion remained as an
independent prognostic factor (p Z 0.001). Related to mortality, negative prognostic factors
were age (p Z 0.003), leukocytosis (p Z 0.048), American Society of Anesthesiologists (ASA)
score (p < 0.001), blood transfusion (p < 0.001), pleural effusion (pZ 0.031), and pneumonia
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74 R. Gianchandani Moorjani et al.Conclusion: Blood loss is the most important prognostic factor for postoperative complications
after nontraumatic splenectomies. Pneumonia is the main prognosis factor for perioperative
mortality.
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reserved.1. Introduction
Splenectomy is a common surgical procedure related to
spleen trauma. However, many other elective surgical
indications for splenectomy have been described in non-
trauma patients including hematological disorders, lym-
phoma staging, and primary tumors of the spleen. In fact,
splenic surgery is indicated in an interesting and wide va-
riety of disease processes.1e3
There are many studies in which the prognosis factors
related to the morbidity and mortality in traumatic sple-
nectomies have been analyzed.4e6 However, very few
studies of the prognosis factors in nontraumatic splenec-
tomies have been reported.7e10
The aim of this study was to identify and analyze factors
related to the perioperative morbidity and mortality in
elective, nontraumatic splenectomies.2. Patients and methods
A descriptive cross-sectional study of 152 consecutive,
nonselected, nontraumatic patients operated on by sple-
nectomy between 1996 and 2010 was carried out. Regis-
tration of the patient’s medical data in an electronic
database was recorded according to the guidelines of the
Ethics Committee of our institution. The authorization to
use these data was given by the patients in a written and
informed consent. The setting was a tertiary-care hospital
that attends a population of approximately 400,000 people.
Exclusion criteria included incidental splenectomies, and
splenectomies performed during en-bloc resection for ma-
lignancy in an adjacent organ, such as the stomach, colon,
adrenal gland, or pancreas.
The following variables were recorded:
(1) Clinical data: age, sex, the anesthetic risk evaluation
according to the American Society of Anesthesiologists
score (ASA), splenic disorders that indicated the sple-
nectomy, splenomegaly, and hypersplenism. In accor-
dance with the European Association for Endoscopic
Surgery (EAES) guidelines,11 splenomegaly was defined
as a long axis exceeding 15 cm, as measured by ultra-
sound along its longer dimension. Hypersplenism12 was
defined by thrombocytopenia and/or neutropenia
resulting from blood cell sequestration in an enlarged
spleen; in some cases, this can also be responsible for
mild anemia. The definitive diagnostic of the splenic
disorder was obtained from the histopathological study
of the removed spleen.
(2) Preoperative laboratory variables: anemia
(hemoglobin < 13 g/dL in males and < 12 g/dL infemales), leukocytosis (> 11  109/L), leukopenia
(< 4  109/L), and thrombopenia (< 100  109/L).
(3) Surgical variables: surgical procedure (laparoscopic vs.
nonlaparoscopic approach), total surgical time (defined
as the time from the skin incision for portal placement
to the end of skin suturing), and perioperative blood
transfusions.
(4) Macroscopic histological findings: size (centimeters)
and weight (grams) of the specimen of spleen removed.
(5) Postoperative variables: postoperative hospital stay,
perioperative complications, and perioperative mor-
tality. Perioperative mortality was defined either as any
death occurring within 30 days of surgery or any later
death that was considered to be a direct consequence
of a postoperative complication. To evaluate the
severity of the complications, the Clavien-Dindo clas-
sification13,14 was used: Grade I and Grade II are com-
plications that include only minor deteriorations from
the normal postoperative course and can be easily
treated with drugs, blood transfusion, and nutritional
supply; Grade III complications require interventional
treatment; Grade IV complications are life-threatening
complications with intensive care unit management;
and Grade V means death of the patient.
Univariate analyses were performed to compare each
independent variable (age, sex, ASA, splenic disorders,
splenomegaly, hypersplenism, surgical procedure, surgical
time, blood transfusions, and size and weight of the
removed spleen) with either the morbidity (Clavien-Dindo
Grades I and II vs. Grades III and IV) and mortality variables.
Two models of multivariate analysis were created in order
to identify risk factors of postoperative morbidity and
perioperative mortality, respectively.
2.1. Statistical analysis
Data were analyzed using the statistical package SPSS
version 15.0 for Windows (SPSS Inc., Chicago, IL, USA).
Results of continuous variables were given as mean
[ standard deviation (SD), confidence interval (95% CI)].
Categorical variables were expressed as percentages. The
Chi-square test or Fisher’s test was used to compare cate-
gorical data. For the parametric distribution, Student t test
or one-way analysis of variance (ANOVA) test were used to
compare the mean values of two or more groups, respec-
tively. For nonparametric variables, the Mann-Whitney
U test or the Kruskal-Wallis test were used to compare
the median values of the response variable. Two stepwise
logistic regression analyses were performed. In the first
model, the outcome variable was “postoperative compli-
cations”, and in the second model, the outcome variable
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variables. Each model included as explanatory or predictor
factors the variables that were suggested in the univariate
analysis to be more strongly and significantly associated
with complications or mortality. A p < 0.05 level was used
for the inclusion of the variables in the model. When two or
more explanatory variables were correlated, only the var-
iable with the strongest relationship with the outcome
variable was included in the model. These analyses were
designed to establish independent risk factors of morbidity
and mortality for nontraumatic splenectomy. The 95% CI
was determined as an indication of the precision of an es-
timate of a population value. The odds ratio (OR) was
calculated as an estimate of relative risk between two
groups on the basis of the mortality as outcome. Statistical
significance was defined as p < 0.05.91
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Figure 1 Overall postoperative complications after non-
traumatic splenectomy according to the Clavien-Dindo score.3. Results
Out of the 152 patients, 89 (58.6%) were male and 63
(41.4%) were female. The mean  SD age was 49.8  17.8
years (95% CI: 46.9e52.6), with an age range of 14e83
years, and the median age was 53 years (interquartile
range: 29). The distribution of the anesthetic risk scale ASA
was as follows: 15 patients were ASA I (9.9%), 63 patients
were ASA II (41.4%), 53 patients were ASA III, and 21 pa-
tients were ASA IV (13.8%).
Seventy-four patients (48.7%) were operated on for
malignant hematologic disorders: 64 lymphomas and 10
myeloproliferative syndromes. In 30 patients (19.7%), the
indication for splenectomy was a benign hematologic dis-
order: idiopathic thrombocytopenic purpura (ITP). Four-
teen splenectomized patients (9.2%) suffered hemolytic
anemia: hereditary spherocytosis (10 cases), Louis-Ville
hemoglobinopathy (two cases), autoimmune hemolytic
anemia (one case), congenital dyserythropoiesis (one case).
In nine patients (5.9%), a vascular disorder indicated the
splenectomy: portal hypertension (six cases), and aneurysm
of splenic artery (three cases). In another nine patients
(5.9%), the splenectomy was performed because of a
benign neoplasm: hemangioma (two cases) and splenic
cysts (two cases). An infectious disease was diagnosed in
eight cases (5.3%): splenic abscesses (four cases), leish-
maniasis (one case), chronic granulomatous disease (one
case), mycotic splenic artery aneurysm (one case), and
splenic atypical mycobacterial disease (one case). Another
eight patients were included in a miscellaneous group:
amyloidosis (one case), nonspecific lymphoid hyperplasia
(two cases), metastasis of squamous cell carcinoma (one
case), systemic lupus erythematosus (one case), Wegener’s
granulomatosis (one case), and normal spleen (three
cases).
The spleen was enlarged in 95 patients (62.5%). This
data could not be recorded in one patient. Hypersplenism
was diagnosed in 78 patients (51.3%).
One hundred and four patients were operated by lapa-
rotomy (68.4%). In the remaining 48 patients, a laparo-
scopic approach was initially carried out, but the
conversion of the procedure to open surgery was necessary
in 11 cases (22.9%). The mean surgical time was
127.1  44.6 minutes, the range was 45e285 minutes, andthe median surgical time was 120 minutes (interquartile
range: 55). Perioperatively, 66 patients (43.4%) underwent
at least one blood transfusion.
The mean size of the spleen specimens removed was
18.1  5.9 cm, range 7e32, and the median size was 18 cm.
(interquartile range: 9). The mean weight  SD of the
specimens removed was 855.9  779.3 g, the range was
39e3905 g, and the median weight was 581.5 g (inter-
quartile range: 1062).
Seventeen patients (11.1%) were re-operated on. The
overall postoperative complication rate following non-
traumatic splenectomy in this series of 152 patients was
40.1%: pleural effusion (28 patients), subphrenic collection
(15 cases), ileus (15 patients), pneumonia (13 cases),
wound infection (10 cases), atelectasis (nine cases),
hyperamilasemia (five cases), pancreas pseudocyst (four
cases), and pneumothorax (three patients).
At least one complication was detected in 61 patients
(Fig. 1). Clavien-Dindo Grade I and Grade II complications
were found in 16 cases and 11 cases, respectively, Grade
IIIa in nine patients (5,9%), Grade IIIb in 9 patients, and
Grade IV in five patients (3.3%).
Perioperative mortality (Grade V) was 7.2% (11 pa-
tients). The causes of death included septic shock in three
patients, multiple organ failure in six patients, liver failure
in one patient, and hypovolemic shock due to bleeding in
one patient.
In the univariate analysis, the factors related to com-
plications according Clavien-Dindo score are shown in
Table 1. Significant univariate negative predictors were the
variables age (pZ 0.004), anemia (pZ 0.03), leukocytosis
(p Z 0.016), and perioperative blood transfusions
(p Z 0.029). Significant favorable predictors were the
presence of thrombocytopenic purpura (p Z 0.01) and
laparoscopic approach (p Z 0.059). In the multivariate
analysis (Table 2) only the need for perioperative blood
transfusion remained as an independent prognostic factor
of morbidity (p Z 0.001; OR: 3.50; 95% CI: 1.67e7.34).
Univariate analyses of mortality-related factors are
summarized in Table 3. Age (p Z 0.003), leukocytosis
(p Z 0.048), ASA score (p < 0.001), perioperative blood
transfusion (p Z 0.001), postoperative pleural effusion
(p Z 0.031), and postoperative pneumonia (p Z 0.001)
were associated with mortality in a statistically significant
way. Nevertheless, only pneumonia as a postoperative
complication was identified as independent risk of
Table 1 Univariate predictors of postoperative complications after nontraumatic splenectomy.
Parameter N (%) Clavien-Dindo
Grade 0
n Z 91 (59.9%)
Clavien-Dindo
Grades I and II
n Z 27 (17.8%)
Clavien-Dindo
Grades IIIeV
n Z 34 (22.4%)
p
Preoperative status
Age (mean  SD) 152 46.0  17.1 53.9  16.0 56.6  18.7 0.004*
Male sex 89 (58.6) 50 (40.9) 17 (63.0) 22 (64.7) 0.539
Anemia 98 (64.5) 551 (56.0) 21 (77.8) 26 (76.5) 0.03*
Leukocytosis 42 (27.6) 20 (22.0) 6 (22.2) 16 (47.1) 0.016*
ASA IIIeIV 74 (48.7) 38 (41.8) 14 (51.9) 22 (64.7) 0.07
Splenomegaly 95 (62.9) 55 (61.1) 19 (70.4) 21 (61.8) 0.674
Hypersplenism 78 (51.3) 44 (48.4) 19 (70.4) 15 (44.1) 0.084
Splenic disorder
Malignant hematologic disorder 74 (48.7) 41 (45.1) 18 (66.7) 15 (44.1) 0.119
Thrombocytopenic purpura 30 (19.7) 25 (27.5) 1 (3.7) 4 (11.8) 0.01*
Hemolytic anemia 14 (9.2) 10 (11.0) 3 (11.1) 1 (2.9) 0.360
Surgical variables
Laparoscopic approach 37 (24.3) 29 (31.9) 4 (14.8) 4 (11.8) 0.029*
Perioperative transfusions 66 (43.4) 26 (28.6) 14 (51.9) 26 (76.5) < 0.001*
Surgical time (mean  SD) 152 123.8  46.2 130.2  48.0 133.4  37.6 0.524
Specimen removed
Size (cm) (mean  SD) 152 17.6  5.7 19.5  6.2 17.9  6.2 0.351
Weight (g) (mean  SD) 152 770.1  683.9 986.7  739.9 981.5  1010.6 0.255
*Statistically significant.
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95% CI: 1.2e24.85; Table 4).4. Discussion
Splenectomy in nontrauma patients is a frequent surgery
for diagnosis and therapeutic indications, and is related to
a high rate of complications, but very few papers have been
published on this topic.9,10
The prevalence of morbidity associated with non-
traumatic splenectomies ranges between 27% and 52%.710
This wide range could be because a lack of uniform
reporting of negative outcomes, which makes interpreta-
tion of surgical literature difficult. Clavien and Dindo
have13,14 have introduced an interesting grading system of
postoperative complications, i.e., a five-scale classification
system with the aim of presenting an objective, simple,
reliable, and reproducible way of reporting allTable 2 Multivariate analysis of risk factors associated with po
Parameter B SE
Age 0.014 0.012
Leukocytosis 0.516 0.408
Thrombocytopenic purpura 0.624 0.588
Laparoscopic surgery 0.466 0.507
Blood transfusion 1.252 0.378
Constant 1.637 0.705
* Statistically significant.
B Z regression coefficient; CI Z confidence interval; OR Z odds ratcomplications after surgery. Few studies have used this
score for postoperative complications in splenectomy.15 We
consider that this classification represents an objective and
simple way of reporting all complications in patients un-
dergoing splenectomies. In our study, the overall morbidity
rate was found to be 40%. Nevertheless, complications of
the Clavien-Dindo Types III and IV were only 22.4%.
According to the literature findings, the most common
postoperative side-effects after this procedure are the
pulmonary complications. Globally, these complications
may arise in 32% of the patients,10 and include pleural
effusion, atelectasis, pneumonia, and bronchitis. Sub-
phrenic abscess is also a common complication reported in
previous articles7,8,10 with a range of 3e6%, which is com-
parable with our findings.
In Dawson et al’s series,16 pneumonia occurred in 13% of
patients, and Aksnes et al7 reported postoperative pneu-
monia in 17%. Wiseman et al17 also reported that splenec-
tomy is associated with an increase in early postoperativestoperative complications after nontraumatic splenectomy.
Wald p OR (95% CI)
1.330 0.249 1.01 (0.99e1.04)
1.596 0.206 1.68 (0.75e3.73)
1.125 0.289 0.54 (0.17e1.70)
0.846 0.358 0.63 (0.23e1.69)
10.953 0.001* 3.50 (1.67e7.34)
5.397 0.020
io; SE Z standard error; Wald Z test statistic.
Table 3 Univariate predictors of perioperative mortality after nontraumatic splenectomy.
N (%) Alive
n Z 141 (92.8%)
Dead
n Z 11 (7.2%)
p OR (95% CI)
Preoperative status
Age (mean  SD) 152 48.6  17.3 64.7  17.4 0.003* d
Male sex 89 (58.6) 80 (56.7) 9 (81.8) 0.124 0.29 (0.06e1.39)
Anemia 98 (64.5) 88 (62.4) 10 (90.9) 0.05 6.02 (0.75e48.39)
Leukocytosis 42 (27.6) 36 (25.5) 6 (54.5) 0.048* 3.50 (1.01e12.16)
ASA IIIeIV 74 (48.7) 63 (44.7) 11 (100) < 0.001* 1.18 (1.07e1.29)
Splenomegaly 95 (62.9) 86 (61.4) 9 (81.8) 0.153 2.83 (0.59e13.58)
Hypersplenism 78 (51.3) 72 (51.1) 6 (54.5) 0.824 1.15 (0.34e3.94)
Splenic disorder
Malignant hematologic disorder 74 (48.7) 67 (47.5) 7 (63.6) 0.303 1.93 (0.54e6.90)
Thrombocytopenic purpura 30 (19.7) 29 (20.6) 1 (9.1) 0.320 0.39 (0.05e3.14)
Hemolytic anemia 14 (9.2) 14 (9.9) 0 (0.0) 0.332 0.92 (0.88e0.97)
Surgical variables
Laparoscopic approach 37 (24.3) 36 (25.5) 1 (9.1) 0.200 0.29 (0.04e2.36)
Perioperative transfusions 66 (43.4) 55 (39.0) 11 (100) < 0.001* 1.2 (1.08e1.34)
Surgical time (mean  SD) 152 126.5  44.6 135  46.2 0.543 d
Specimen removed
Size (cm) (mean  SD) 152 18.0  6.1 17.8  4.4 0.914 d
Weight (g) (mean  SD) 152 854.7  796.4 871.2  537.9 0.946 d
Postoperative complications
Pleural effusion 28 (18.4) 23 (16.3) 5 (45.5) 0.031* 4.28 (1.20e15.20)
Subphrenic collection 15 (9.9) 12 (8.5) 3 (27.3) 0.079 4.03 (0.94e17.20)
Ileus 15 (9.9) 12 (8.5) 3 (27.3) 0.079 4.03 (0.94e17.20)
Pneumonia 13 (8.6) 8 (5.7) 5 (45.5) 0.001* 13.85 (3.47e55.33)
Wound infection 10 (6.6) 8 (5.7) 2 (18.2) 0.156 3.69 (0.68e20.03)
*Statistically significant.
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pneumonia (30%). This data support that infection diseases,
especially pneumonia, are a common complication after
splenectomy, probably due to immunosupression.
Splenectomy is recognized as a cause of portal, mesen-
teric, and splenic vein thrombosis, a potentially life-
threatening complication that can occur within months
after splenectomy18. The clinical spectrum ranges from
undefined and nonspecific symptoms to intestinal infarction
and portal hypertension. However, the exact incidence of
the complications and its predisposing factors are not
clearly defined. The reported rate of thrombosis widely
varies depending on the diagnostic method used. In the
review performed by Krauth et al,19 the overall risk of all
reviewed studies combined was 3.3%. Risk factors were bigTable 4 Multivariate analysis of risk factors associated with pe
Parameter B SE
Age (y) 0.016 0.025
ASA classification 1.007 0.568
Blood transfusion 1.654 1.131
Pneumonia 1.721 0.761
Constant 7.886 2.007
*Statistically significant.
B Z regression coefficient; CI Z confidence interval; OR Z odds ratispleens and hereditary hemolytic anemia, whereas the risk
was low in autoimmune thrombocytopenia and trauma. To
date, the role of the surgical approach, laparoscopic sur-
gery, or open surgery is also unclear. Whereas some studies
have shown no influence of surgical technique on the inci-
dence of portal and splenic vein thrombosis, others have
reported a significantly higher incidence of the complica-
tion after laparoscopic surgery.11 In our series, no portal/
splenic vein thrombosis was detected in the early post-
operative period.
Many preoperative factors have been described to pre-
dict complications. Age of patients has been reported to be
a prognosis factor for morbidity.20 Elderly patients with
hematological disorders requiring splenectomy are in a
special group, in which the underlying disease by itself isrioperative mortality of nontraumatic splenectomy.
Wald p OR (95% CI)
0.416 0.519 1.02 (0.97e1.07)
3.143 0.076 2.74 (0.90e8.33)
2.140 0.144 5.23 (0.57e47.95)
5.116 0.024* 5.59 (1.26e24.85)
15.445 0.000
o; SE Z standard error; Wald Z test statistic.
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morbidity. In our study, we found that elderly patients had
significantly more complications, as is described in other
studies.7,8
Regarding splenomegaly, the literature presents no
unanimous use of this term. The normal spleen size is up to
12 cm, and anything larger than that is classified as
splenomegaly, which could be moderate, within a range of
11e20 cm, or severe, more than 20 cm. However, we
considered splenomegaly as a long axis exceeding 15 cm,
according to the EAES guidelines11. This variable did not
correlate with perioperative complications in our series.
Several authors have defined splenomegaly in terms of
weight. Horowitz et al10 reported a rate of complications of
63% for patients whose spleens after splenectomy for he-
matologic malignancies weighed greater than 2000 g, and
29% for patients whose spleens weighed less than 2000 g.
Danforth et al21 reported that the postoperative compli-
cation rate after splenectomy from massive splenomegaly
( 1500 g) was 39.1%. In both cases, the splenic weight, as
significant predictor of postoperative morbidity, was due to
greater blood loss during surgery.
In fact, a spleen weight > 2000 g has been reported to
stand out as the main determinant of operative blood loss
resulting in more complications.10,21 However, our findings
are similar to that of Al Harbi et al8 and McAneny et al,22
who showed that the weight of the spleen has no effect
on morbidity. Moreover, a definition by weight does not
seem appropriate because the weight can be obtained only
postoperatively and has no predictive value for the choice
of surgical approach.11
Indication for splenectomy23,24 is also a determinant
factor for postoperative complications. Malignant diseases
have more complications than autoimmune disease, which
have less complications because of their underlying medical
condition. In our series, patients with malignant hemato-
logical disease had more complications, compared with
idiopathic thrombocytopenic purpura and hemolytic ane-
mia. In particular, ITP was a predictor factor for fewer
complications in univariate analysis. Many reports show
that ITP is related to minimal blood loss, short hospital stay,
and less negative outcome, especially when it is performed
laparoscopically.23
In many centers, laparoscopic splenectomy has become
the standard approach for most cases of elective splenec-
tomy, and is associated with reduced morbidity, especially
pulmonary, wound, and infectious complications.25 In our
series, this approach was also related to fewer complica-
tions, similar to results reported by others. Maurus et al26
reported an overall complication rate much higher in
open versus laparoscopic splenectomies, including less
blood loss. Probably, the fewer complications could be
related to there being more selected patients who under-
went a laparoscopic approach. We had a relatively high rate
of conversion (22.9%), which can be explained by the long
time interval of our analysis series, between 1996 and 2010,
which includes the learning curve of laparoscopy in our
hospital.
We also found that preoperative anemia and leukocy-
tosis were predictive negative factors for morbidity. Ane-
mia is not reported to be a related factor in previous papers
about this issue, but patients with hematologic malignancywith leukocytosis are described to have more
complications.10
Blood transfusion was the only independent risk factor
for morbidity in the multivariate analysis. It has been re-
ported in other previous studies710 as one of the main
predictors of postoperative complications. Many studies
have shown that blood transfusions suppress immune
function27 and are related to an increased number of
postoperative complications and length of hospital stay.28
This variable was also a significant risk factor for mortal-
ity in the univariate analysis, but it was not an independent
prognostic factor in multivariate analysis.
In this series, other examined variables were found to
have no significant impact on morbidity, such as surgical
time and ASA score. This may be because the ASA score is a
predictor for postoperative mortality rather than for
complications.
Regarding mortality, our series had a rate of 7.2%, which
compares well the 6-9% rate reported in the literature.810
The direct cause of death in our series was multiple organ
failure and sepsis, probably due to immunosupression after
splenectomy. This is according to Johnson and Deterling,29
who reported that the direct cause of mortality was sepsis
in 36% of patients. However, bleeding was the main cause
of death in other series reviewed,8 where many patients
had portal hypertension.
Reported predictors factors for mortality in the litera-
ture7,8 are age, blood transfusion, thoraco-abdominal
approach, operative time, and chest infection. In this
study, we found that significant predictors for mortality
were age, leukocytosis, ASA score, blood transfusion,
pleural effusion, and pneumonia. However, only pneumonia
was an independent negative prognostic factor for periop-
erative death.
The main limitation of this study comes from its retro-
spective design. Moreover, this study included patients
from a long period of time, during which there have been
many improvements in surgery, antibiotics, and anes-
thetics, which could cause fewer rates of complications.
In conclusion, the morbidity and mortality in non-
traumatic splenectomies are relatively high, probably due
to immunosuppressed patients. Blood loss, as in other types
of surgery, such as liver or pancreatic surgery, is the most
important prognostic factor for postoperative complica-
tions. Infection is the main prognostic factor for perioper-
ative mortality.References
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